Cost-benefit analysis of the FDA : the case of the prescription drug user fee acts
Year of publication: |
2008
|
---|---|
Authors: | Philipson, Tomas J. ; Berndt, Ernst R. ; Gottschalk, Adrian H. B. ; Sun, Eric |
Published in: |
Journal of public economics. - Amsterdam [u.a.] : Elsevier, ISSN 0047-2727, ZDB-ID 183995-0. - Vol. 92.2008, 5/6, p. 1306-1325
|
Subject: | USA / Food and Drug Administration | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Aufsichtsbehörde | Regulatory agency | Kosten-Nutzen-Analyse | Cost-benefit analysis | Wirkungsanalyse | Impact assessment | USA | United States |
-
Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2005)
-
Overdose : how excessive government regulation stifles pharmaceutical innovation
Epstein, Richard A., (2006)
-
Drug shortages, pricing, and regulatory activity
Stomberg, Christopher, (2016)
- More ...
-
Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts
Philipson, Tomas J., (2007)
-
Cost-benefit analysis of the FDA : the case of the Prescription Drug User Fee Acts
Philipson, Tomas J., (2007)
-
Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2005)
- More ...